These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20379852)

  • 1. Modelling the transmission dynamics and control of the novel 2009 swine influenza (H1N1) pandemic.
    Sharomi O; Podder CN; Gumel AB; Mahmud SM; Rubinstein E
    Bull Math Biol; 2011 Mar; 73(3):515-48. PubMed ID: 20379852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
    Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pandemic 2009 (A)H1N1 influenza (swine flu) - the Manitoba experience.
    Embree J
    Biochem Cell Biol; 2010 Aug; 88(4):589-93. PubMed ID: 20651829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pandemic (H1N1) 2009 influenza in hospitalized children in Manitoba: nosocomial transmission and lessons learned from the first wave.
    Fanella ST; Pinto MA; Bridger NA; Bullard JM; Coombs JM; Crockett ME; Olekson KL; Poliquin PG; Van Caeseele PG; Embree JE
    Infect Control Hosp Epidemiol; 2011 May; 32(5):435-43. PubMed ID: 21515973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public health management of pandemic (H1N1) 2009 infection in Australia: a failure!
    Waterer GW; Hui DS; Jenkins CR
    Respirology; 2010 Jan; 15(1):51-6. PubMed ID: 20199635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling optimal age-specific vaccination strategies against pandemic influenza.
    Lee S; Golinski M; Chowell G
    Bull Math Biol; 2012 Apr; 74(4):958-80. PubMed ID: 22147102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changing management of pandemic influenza].
    Morikane K
    Rinsho Byori; 2010 Mar; 58(3):254-62. PubMed ID: 20408444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative analysis of the level of cross-protection between epidemic waves of the 1918-1919 influenza pandemic.
    Rios-Doria D; Chowell G
    J Theor Biol; 2009 Dec; 261(4):584-92. PubMed ID: 19703472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mathematical modeling of the novel influenza A (H1N1) virus and evaluation of the epidemic response strategies in the Republic of Korea].
    Suh M; Lee J; Chi HJ; Kim YK; Kang DY; Hur NW; Ha KH; Lee DH; Kim CS
    J Prev Med Public Health; 2010 Mar; 43(2):109-16. PubMed ID: 20383043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal, avian, and novel H1N1 influenza: prevention and treatment modalities.
    Sym D; Patel PN; El-Chaar GM
    Ann Pharmacother; 2009 Dec; 43(12):2001-11. PubMed ID: 19920156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza epidemiology--past, present, and future.
    Lagacé-Wiens PR; Rubinstein E; Gumel A
    Crit Care Med; 2010 Apr; 38(4 Suppl):e1-9. PubMed ID: 20029350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
    Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
    Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(44):1241-5. PubMed ID: 19910912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving clinical equality in an influenza pandemic: patent realities.
    Kane EM
    Seton Hall Law Rev; 2009; 39(4):1137-72. PubMed ID: 20718133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perspective on the 2009 A/H1N1 influenza pandemic in Mexico.
    Acuña-Soto R; Castañeda-Davila L; Chowell G
    Math Biosci Eng; 2011 Jan; 8(1):223-38. PubMed ID: 21361409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative evaluation on the effectiveness of prevention and control measures against pandemic influenza A (H1N1) in Beijing, 2009].
    Wang XL; Yang P; Cao ZD; Zeng DJ; Wu J; Zahng Y; Qian HK; Peng XM; Liang HJ; Pang XH; Deng Y; He X; Wang QY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1374-8. PubMed ID: 21223667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of atopic children with pandemic H1N1 influenza viral infection: pandemic H1N1 influenza reveals 'occult' asthma of childhood.
    Hasegawa S; Hirano R; Hashimoto K; Haneda Y; Shirabe K; Ichiyama T
    Pediatr Allergy Immunol; 2011 Feb; 22(1 Pt 2):e119-23. PubMed ID: 21342277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic influenza A (H1N1) 2009 vaccine: an update.
    Goel MK; Goel M; Khanna P; Mittal K
    Indian J Med Microbiol; 2011; 29(1):13-8. PubMed ID: 21304188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral treatment for pandemic influenza: assessing potential repercussions using a seasonally forced SIR model.
    Towers S; Vogt Geisse K; Zheng Y; Feng Z
    J Theor Biol; 2011 Nov; 289():259-68. PubMed ID: 21867715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.